PRIME PAC® PRRS RR
Porcine Reproductive & Respiratory Syndrome Vaccine
Product Description
This product has been shown to be effective for the vaccination of healthy swine 3 weeks of age or older against respiratory disease caused by Porcine Reproductive and Respiratory Syndrome (PRRS) virus and female breeding age swine against reproductive disease caused by PRRS virus.
Indications
Prime Pac PRRS RR is recommended for use in healthy swine from herds with a PRRS virus-positive history according to label direction. Recommended use shall be restricted to premises having a history of the disease.
Advantages
- Prime Pac® PRRS RR is a safe product to include in your respiratory and reproductive disease prevention protocols.
- Licensing data demonstrates good cross-protection in the face of a heterologous PRRSV challenge.
- Keeps pigs healthy in the face of a heterologous PRRSV challenge.
- Duration of Immunity against reproductive disease is at least 20 weeks.
- Convenient 1mL dose.
Supplied
100 doses – Rehydrate to 100 mL
20 doses – Rehydrate to 20 mL
Downloads
- Product Bulletin Porcine Reproductive and Respiratory Syndrome vaccine
- Reproductive Technical Services Bulletin Efficacy and field safety of Prime Pac® PRRS RR against reproductive disease caused by Porcine Reproductive and Respiratory Syndrome virus
- Respiratory Technical Services Bulletin Efficacy and field safety of Prime Pac® PRRS RR against respiratory disease caused by Porcine Reproductive and Respiratory Syndrome virus
For additional information, please see the product label.
Go To United States
Algeria
Argentina
Australia
Austria
Bahrain
Belgium (Dutch)
Brazil
Canada (English)
Chile
Colombia
Croatia
Czech Republic
Denmark
Ecuador
Egypt
Finland
France
Germany
Greece
Hungary
India
Indonesia
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kuwait
Lebanon
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Oman
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Saudi Arabia
South Africa
South Korea
Spain
Sweden
Switzerland (French)
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Yemen
Global